Posts Tagged ‘XCO’

Pandora Call Options Pop As Shares Improve


Today’s tickers: P, CBS & XCO

P - Pandora Media, Inc. – Traders that appear to be speculating on a rebound in shares of the provider of Internet radio services turned-up the volume in Pandora Media call options today. Shares in Pandora, which have been beaten down in recent months, increased as much as 10.5% to $8.91 in the first half of the session before losing some steam to stand up 4.9% on the day at $8.45 as of 1:15 p.m. ET. The stock is down 15.0% year-to-date and more than 65.0% since touching a peak value of $26.00 at the June 2011 IPO. June expiry call options saw the most action today, with the $9.0 strike call changing hands more than 6,700 times versus open interest of just 354 contracts. Most of the $9.0 calls appear to have been purchased for an average premium of $0.76 apiece. Call buyers profit at expiration as long as shares in Pandora jump 15.0% to surpass the average breakeven point at $9.76 by June expiration. Traders positioning for shares to extend gains also snapped up around 1,000 in-the-money calls at the June $8.0 strike for a premium of $1.10 a-pop. Pandora Media, Inc. is slated to release first-quarter earnings after the market closes on May 24th.

CBS - CBS Corp. – A burst of call buying on CBS Corp. caught our eye today, with shares in the name trading up 1.2% at $33.31 in early-afternoon trade. The bulk of the options volume in the mass media company appears to be betting on continued near-term appreciation in the price of the underlying shares, perhaps ahead of the Company's first quarter earnings release after the final bell on May 1st. The most active contracts in play on CBS Corp. today are the May…
continue reading


Tags: , ,




Contrarian Player Positions for Rebound in Cytokinetics Shares in 2011

 Today’s tickers: CYTK, SNDK, XCO, GIII & CFN

CYTK - Cytokinetics, Inc. – One bullish options investor appears to be taking advantage of the massive pullback in the price of the biopharmaceutical company’s shares today by initiating a sizeable buy-write strategy using call options expiring in June of 2011. Cytokinetics’ shares fell as much as 23.2% during the session to touch an intraday low of $2.25 despite seemingly positive results from its Phase 2a trial of its experimental drug therapy aimed at improving quality of life for patients suffering from Lou Gehrig’s disease. Reports indicated the firm plans to launch another mid-stage trial to test multiple doses of the drug over a three-month period in the first half of 2011. The covered-call seller populating CYTK today is well positioned to benefit from a rebound in the price of the underlying shares in the first half of 2011. It looks like the investor purchased 395,000 shares of CYTK at a price of $2.32 each, and sold 3,950 calls at the June 2011 $2.5 strike for a premium of $0.45 a-pop. The sale of the call options effectively reduces the price paid to get long the stock from $2.32 a share to $1.87 each. Thus, the buy-write strategist is positioned to accrue maximum gains of 33.7% on the long stock position in the event that Cytokinetics’ shares surge 11.1% over today’s low of $2.25 to exceed $2.50 a share ahead of expiration day in June. The investor may have the underlying stock position called from him at $2.50 each if the calls land in-the-money at expiration, thus allowing him to exit the position with the 33.7% rise in shares from $1.87 to $2.50. More than 4,050 calls changed hands at the June 2011 $2.5 strike today, versus previously existing open interest of just 451 contracts at that strike.

SNDK - SanDisk Corp. – Bulls are picking up in- and out-of-the-money call options on the maker of flash-based storage products once again today with shares in SanDisk Corp. trading…
continue reading


Tags: , , , ,




Bearish Player Initiates Ratio Put Spread at Staples

Today’s tickers: SPLS, XCO, THC, FTO, YHOO, ERTS, LNC & GE

SPLS - Staples, Inc. – The supplier of office products popped up on our ‘hot by options volume’ market scanner late in the trading session after one investor initiated a bearish spread in the December contract. Staples’ shares are currently down 0.80% at $20.64 as of 3:15 p.m. in New York. The pessimistic player established a ratio put spread, buying 2,500 in-the-money puts at the December $21 strike for an average premium of $1.185 each, and selling 5,000 puts at the lower December $19 strike at an average premium of $0.39 apiece. The average net cost of the transaction amounts to $0.405 per contract. Thus, the investor is prepared to make money if the price of the underlying stock slips beneath the effective breakeven point on the spread at $20.595 by expiration day in December. Maximum potential profits of $1.595 per contract are available to the ratio-spreader if the office products company’s shares fall 7.945% from the current price of $20.64 to settle at $19.00 at expiration. The investor is vulnerable to losses in the event that Staples’ shares plummet far lower than he expects they will in the next several months. Losses start to accumulate for the trader if shares drop 15.7% lower and trade below the lower breakeven point at $17.405 by expiration day. Staples, Inc. is slated to report third-quarter earnings ahead of the opening bell on November 18, 2010.

XCO - EXCO Resources, Inc. – The oil and natural gas company was visited by one long-term bullish options investor in the second half of the trading session. It looks like the trader is expecting EXCO’s shares to rally significantly by expiration day in March of 2011. Shares of the Dallas, TX-based firm are up 2.05% at…
continue reading


Tags: , , , , , , ,




Strangle Strategist Targets VeriSign Options

Today’s tickers: VRSN, CAT, EWZ & XCO

VRSN – VeriSign, Inc. – Symantec Corp. agreed to shell out $1.28 billion in cash to purchase VeriSign Inc.’s authentication services unit in a deal reportedly set to close by the end of September. Despite securing a buyer for its unit, which certifies that websites are legitimate and safe for online transactions, VeriSign’s shares are lower by 1.75% to stand at $27.50 as of 11:20 am (ET). VeriSign received an upgrade to ‘buy’ from ‘hold’ at Deutsche Bank today where analysts tout a 12-month target share price of $35.00 on the stock. One options strategist expecting shares of the underlying stock to remain range-bound through September expiration sold a strangle to reap the benefits of inflated options implied volatility. The investor sold 10,300 calls at the September $31 strike for a premium of $1.00 each and sold the same number of puts at the lower September $28 strike for $2.85 apiece. Gross premium pocketed on the transaction amounts to $3.85 per contract. The trader keeps the full premium received on the sale as long as shares trade within the range of the strike prices described through expiration. The short sale of both call and put options expose the investor to potential losses should shares rally above the upper breakeven price of $34.85, or if shares slip beneath the lower breakeven point at $24.15, ahead of expiration. Another investor opted to take profits off the table by selling a previously established long call position in the September contract. Perhaps the trader is taking in whatever profits are available now in case shares continue lower ahead of expiration. It looks like the investor originally purchased at least 15,000 calls at the September $28 strike for an average premium of $1.45 apiece back on April 15, 2010, when shares were trading at a volume-weighted average premium of $26.84. Today the options trader sold 15,000 calls at that strike for a premium of $2.15 each, receiving net profits of $0.70 per contract. In hindsight the investor could have raked in more substantial gains had he sold the calls yesterday when VeriSign’s shares surged to a 52-week high of $29.23 on the news Symantec Corp. agreed to buy out the authentication services unit at VRSN.

CAT – Caterpillar, Inc. – Options activity on the machinery manufacturer casts a glimmer of optimism on the stock despite the 4.45% decline…
continue reading


Tags: , , ,




 
 
 

Phil's Favorites

Legal cannabis celebrates its first anniversary in Canada: What's next?

 

Legal cannabis celebrates its first anniversary in Canada: What's next?

Montrealers hold up a Canadian flag with a marijuana logo on it outside a government cannabis store in the city Oct. 17, 2018. THE CANADIAN PRESS/Graham Hughes

Courtesy of Michael J. Armstrong, Brock University

This week marks the first anniversary of Canada’s recreational cannabis legalization. It’s an appropriate time to review what happened last year and consider what’s coming next.

Legalization brought big changes for some folks. About 9,200 employees now work at cannabis producers, with ...



more from Ilene

Zero Hedge

Pork-Panic Sends China CPI To 6 Year Highs As Factory Deflation Deepens

Courtesy of ZeroHedge View original post here.

China's producer prices deflated for the 3rd straight month, slumping 1.2% YoY - the biggest deflationary impulse since July 2016 - but, thanks to the explosion in pork prices (as 'pig ebola' spreads), Chinese consumers are facing the worst inflation since 2013.

  • China Sept CPI +3.0% YoY (2.9% exp and 2.9% prior)

  • China Sept PPI -1.2% YoY (-1.2% exp and -0.8% prior)

...



more from Tyler

Chart School

Review of Andrew CardWell RSI with Wyckoff price waves

Courtesy of Read the Ticker

RSI measures relative strength of price action of a set period versus prior set periods. It helps review the price swings or waves, the power of each price thrust into new ground, or lack of it. Price thrust like many things relies on energy, and energy is not a constant, it has a birth, a life and a death and relative strength helps us see that cycle. 

More from RTT Tv






Chart in video

Click for popup. Clear your browser cache if image is not showing.



...

more from Chart School

Kimble Charting Solutions

Banks Should Send Critical Message To Stocks This Week!

Courtesy of Chris Kimble

Bank earnings could go a long way to impacting the broad market in a big way this week. Wells Fargo, Goldman Sachs, Bank Of America, JP Morgan, Morgan Stanley all announce earning the next couple of days.

As these earning announcements are to take place, the Bank Index (BKX) finds itself facing a key breakout test.

The index remains inside of bullish rising channel (1), as it has created a series of higher lows and higher highs over the past 8-years.

The index has little to brag about over the past 20-months, as it has created a series of lower highs and lower lows inside of falling chan...



more from Kimble C.S.

The Technical Traders

Daily Market Analysis and Trade Setups

Courtesy of Technical Traders

CLICK HERE TO GET REAL TIME TRADE ALERTS!

...

more from Tech. Traders

Insider Scoop

22 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Courtesy of Benzinga

Gainers
  • Reata Pharmaceuticals, Inc. (NASDAQ: RETA) stock surged 45.2% to $146.07 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.8 billion. The most recent rating by Cantor Fitzgerald, on October 15, is at Overweight, with a price target of $180.00.
  • Aphria, Inc. (NYSE: APHA) stock increased by 18.6% to $5.16. The market value of their outstanding shares is at $1.8 billion. According to the most recent rating by CIBC, on July 26, the current rating is at Underperformer.
  • ...


http://www.insidercow.com/ more from Insider

Digital Currencies

Zuck Delays Libra Launch Date Due To Issues "Sensitive To Society"

Courtesy of ZeroHedge View original post here.

Authored by William Suberg via CoinTelegraph.com,

Facebook is taking a much more careful approach to Libra than its previous projects, CEO Mark Zuckerberg has confirmed. 

“Obviously we want to move forward at some point soon [and] not have this take many years to roll out,” he said. “But ...



more from Bitcoin

Lee's Free Thinking

Look Out Bears! Fed New QE Now Up to $165 Billion

Courtesy of Lee Adler

I have been warning for months that the Fed would need new QE to counter the impact of massive waves of Treasury supply. I thought that that would come later, rather than sooner. Sorry folks, wrong about that. The NY Fed announced another round of new TOMO (Temporary Open Market Operations) today.

In addition to the $75 billion in overnight repos that the Fed issued and has been rolling over since Tuesday, next week the Fed will issue another $90 billion. They’ll come in the form of three $30 billion, 14 day repos to be offered next week.

That brings the new Fed QE to a total of $165 billion. Even in the worst days of the financial crisis, I can’t remember the Fed ballooning its balance sheet by $165 bi...



more from Lee

Biotech

The Big Pharma Takeover of Medical Cannabis

Reminder: We are available to chat with Members, comments are found below each post.

 

The Big Pharma Takeover of Medical Cannabis

Courtesy of  , Visual Capitalist

The Big Pharma Takeover of Medical Cannabis

As evidence of cannabis’ many benefits mounts, so does the interest from the global pharmaceutical industry, known as Big Pharma. The entrance of such behemoths will radically transform the cannabis industry—once heavily stigmatized, it is now a potentially game-changing source of growth for countless co...



more from Biotech

Mapping The Market

How IPOs Are Priced

Via Jean Luc 

Funny but probably true:

...

more from M.T.M.

Members' Corner

Despacito - How to Make Money the Old-Fashioned Way - SLOWLY!

Are you ready to retire?  

For most people, the purpose of investing is to build up enough wealth to allow you to retire.  In general, that's usually enough money to reliably generate a year's worth of your average income, each year into your retirement so that that, plus you Social Security, should be enough to pay your bills without having to draw down on your principle.

Unfortunately, as the last decade has shown us, we can't count on bonds to pay us more than 3% and the average return from the stock market over the past 20 years has been erratic - to say the least - with 4 negative years (2000, 2001, 2002 and 2008) and 14 positives, though mostly in the 10% range on the positives.  A string of losses like we had from 2000-02 could easily wipe out a decades worth of gains.

Still, the stock market has been better over the last 10 (7%) an...



more from Our Members

Promotions

Free eBook - "My Top Strategies for 2017"

 

 

Here's a free ebook for you to check out! 

Phil has a chapter in a newly-released eBook that we think you’ll enjoy.

In My Top Strategies for 2017, Phil's chapter is Secret Santa’s Inflation Hedges for 2017.

This chapter isn’t about risk or leverage. Phil present a few smart, practical ideas you can use as a hedge against inflation as well as hedging strategies designed to assist you in staying ahead of the markets.

Some other great content in this free eBook includes:

 

·       How 2017 Will Affect Oil, the US Dollar and the European Union

...

more from Promotions





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>